A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
for Gaucher Disease
Sites in Durham +3 more locations
Sponsor: Prevail Therapeutics
Sex: All·Age: 18+
Code: NCT05487599·Phase 1, Phase 2·Recruiting·Listed Aug 2022